Gary Gellerman
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Organic Chemistry top 5%
- Click Chemistry and Applications
Papers in
-
- Chemical Synthesis and Analysis 19
- Cancer therapeutics and mechanisms 15
- RNA Interference and Gene Delivery 12
-
- Click Chemistry and Applications 12
- Synthesis and Biological Evaluation 8
- Co-authors
- Michael A. Firer (13 shared papers)L. D. Patsenker (33 shared papers)Andrii Bazylevich (23 shared papers)Amnon Albeck (14 shared papers)Bert W. O’Malley (1 shared paper)David M. Lonard (1 shared paper)Yossi Gilad (5 shared papers)Ofer Shpilberg (4 shared papers)
In The Last Decade
Gary Gellerman
83 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 105
- Biomaterials 276
- Organic Chemistry 413
- Molecular Biology 861
- Oncology 311
- Radiology, Nuclear Medicine and Imaging 239
Countries citing papers authored by Gary Gellerman
This map shows the geographic impact of Gary Gellerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Gellerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Gellerman more than expected).
Fields of papers citing papers by Gary Gellerman
This network shows the impact of papers produced by Gary Gellerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Gellerman. The network helps show where Gary Gellerman may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary Gellerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 212 | |
| 2 | 2018 | 151 | |
| 3 | 2021 | 103 | |
| 4 | 2002 | 94 | |
| 5 | 2016 | 75 | |
| 6 | 1998 | 52 | |
| 7 | 2015 | 49 | |
| 8 | 2015 | 48 | |
| 9 | 2020 | 41 | |
| 10 | 2015 | 39 | |
| 11 | 2019 | 34 | |
| 12 | 2016 | 32 | |
| 13 | 2015 | 27 | |
| 14 | 2016 | 27 | |
| 15 | 2018 | 26 | |
| 16 | 2001 | 25 | |
| 17 | 2019 | 24 | |
| 18 | 2001 | 24 | |
| 19 | 2014 | 24 | |
| 20 | 2017 | 23 |
About Gary Gellerman
Gary Gellerman is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 88 papers that have together received 1.7k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (19 papers), Monoclonal and Polyclonal Antibodies Research (15 papers), Cancer therapeutics and mechanisms (15 papers), Photodynamic Therapy Research Studies (14 papers), Nanoplatforms for cancer theranostics (14 papers), RNA Interference and Gene Delivery (12 papers), Click Chemistry and Applications (12 papers) and Synthesis and Biological Evaluation (8 papers). The work is most often cited by research in Biomaterials (276 citations), Organic Chemistry (413 citations), Molecular Biology (861 citations), Oncology (311 citations) and Radiology, Nuclear Medicine and Imaging (239 citations). Gary Gellerman has collaborated with scholars based in Israel, Ukraine and Germany. Frequent co-authors include Michael A. Firer, L. D. Patsenker, Andrii Bazylevich, Amnon Albeck, Bert W. O’Malley, David M. Lonard, Yossi Gilad, Ofer Shpilberg, Bat-Chen R. Avraham-Lubin and Kalimuthu Kalishwaralal. Their work appears in journals such as Dyes and Pigments, Tetrahedron Letters, European Journal of Medicinal Chemistry, Pharmaceutics and Biopolymers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.